$25.80
-2.17 (-7.76%)
Performance
1D
—
1W
-5.43%
1M
-9.60%
3M
-25.09%
6M
-18.66%
1Y
-30.78%
YTD
-27.16%
Open$27.89
Previous Close$27.97
Day High$27.90
Day Low$25.37
52W High$43.15
52W Low$23.82
Volume—
Avg Volume4.53M
Market Cap3.61B
P/E Ratio—
EPS$-4.66
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$30.10
Below
SMA 200
$32.31
Below
RSI (14)
52.4
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+164.4% upside
Current
$25.80
$25.80
Target
$68.21
$68.21
$46.84
$68.21 avg
$80.11
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.82B | 1.78B | 1.68B |
| Net Income | 202.06M | 220.26M | 147.13M |
| Profit Margin | 11.1% | 12.3% | 8.7% |
| EBITDA | 246.26M | 251.94M | 230.42M |
| Free Cash Flow | 210.43M | 219.41M | 153.78M |
| Rev Growth | +17.6% | -0.7% | +11.4% |
| Debt/Equity | 0.22 | 0.23 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |